Clinical TrialsSearch results
Number of results: 932
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Feasibility study of TS-1 after surgery with Cisplatin/Docetaxel in completely resected pathological stage II/IIIA non-small cell lung cancer (TORG0809)
- Non-small Cell Lung Cancer
- Thoracic Oncology Research Group (TORG)
- 2009-04-01
Other
- Randomized trial of platinum based combination chemotherapy with or without Zoledronic acid as first line therapy for non-small cell lung cancer with bone metastases stratified by bone marker (TORG0706).
- Non-small cell carcinoma
- Thoracic Oncology Research Group (TORG)
- 2009-05-01
Other
- A combination phase II study of gemcitabine and S-1 for platinum-refractory patients with non-small cell lung cancer (TORG 0705)
- Non-small cell lung cancer
- Thoracic Oncology Research Group
- 2007-12-01
Other
- Study of Assessment for Kidney function by Urinary microalbumin in RAndomized Trial
- Hypertension with diabetic nephropathy
- The University of Tokyo Graduate School of Medicine
- 2008-07-14
Other
- A Phase III Study of Consolidation Chemotherapy Using UFT plus Cisplatin versus Docetaxel Following Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-18
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Other
- Phase II study of Bevacizumab plus modified OPTIMOX1 in patients with unresectable advanced/recurrent colorectal cancer
- Unresectable advanced/recurrent colorectal cancer
- The Tokyo Cooperative Oncology Group
- 2008-06-01
Other
- Phase II Study of bi-weekly Paclitaxel (TAXOL)for fluorouracil resistant advanced and recurrent Gastric Cancer
- 5-fluorouracil resistant advanced and recurrent Gastric Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-18
Other
- Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
- The Tokyo cooperative oncology group
- 2007-04-01
Other
- Randomized Phase III Trial of Irinotecan plus Cisplatin vs. bi-weekly Irinotecan after S-1 failure for Patients with Advanced and Recurrent Gastric Cancer
- S-1 failure for Patients with Advanced and Recurrent Gastric Cancer
- The Tokyo cooperative oncology group
- 2008-04-01